Laparoskopic Cholecystectomy, Recto Intercostal Nerve Block
Conditions
Keywords
Remifantanile conception, Acute pain, Postoperatif pain
Brief summary
Laparoscopic cholecystectomy is a frequently performed surgery and the gold standard for the treatment of symptomatic gallstone disease. Although laparoscopic cholecystectomy is considered minimally invasive, it can cause moderate to severe pain in the postoperative period. Poorly controlled early postoperative pain impairs recovery quality and increases the risk of postoperative pulmonary complications, serving as a risk factor for chronic pain development. Multimodal analgesia, including opioids, is used to manage pain following laparoscopic cholecystectomy. However, opioid treatment may lead to side effects such as postoperative nausea and vomiting (PONV), respiratory depression, and constipation. The primary aim of this study is to evaluate the effect of recto-intercostal nerve block as part of multimodal analgesia on intraoperative opioid consumption and postoperative pain scores in patients undergoing laparoscopic cholecystectomy.
Interventions
Patients in this group will be administered dexketoprofen 50 mg and tramadol 100 mg intravenously in the intraoperative period. These patients will not receive the rectointercostal nerve block.
The rectointercostal plane block is performed under ultrasound guidance before the surgical procedure and anesthesia induction, with the patient in the supine position. Additionally, patients in this group will be administered dexketoprofen 50 mg and tramadol 100 mg intravenously in the intraoperative period.
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 to 65 years old * American Society of Anesthesiologists (ASA) physical status I-II-III * Elective laparoscopic cholecystectomy surgery
Exclusion criteria
* Under 18 and over 65 years old * ASA score IV and above * Advanced co-morbidity * History of bleeding diathesis * Patient refusing the procedure * Chronic opioid or analgesic use * Patients who will operate under emergency conditions * Block injection site infection * Known allergy to local anesthetics * Pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intraoperative remifentanil consumption | During the intraoperative period | The amount of remifentanil that patients need to maintain anesthesia during the intraoperative period will be recorded |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain scores | First 24 hours after surgery | Pain will be assessed at rest and while movement using the from 0 (no pain) to 10 (worst) |
Countries
Turkey (Türkiye)